The stock of DarioHealth Corp. (NASDAQ:DRIO) is now priced at $6.95 and the shares are 0.13 points up or 1.91% higher compared to its previous closing price of $6.82. The stock had 106109 contracts set over the past session. DRIO shares’ daily volume is compared to its average trading volume at 0 billion shares. However, it has a float of 2.64 million and although its performance was 6.56% over the week, it’s one to watch. Analysts have given the DRIO stock a yearly average price target of $9.33 per share. It means the stock’s upside potential is 34.24% with the DRIO share price recently placing at $6.7083 to $7. However, some brokerage firms have priced the stock below the average, including one that has called $8.

The shorts are running away from the DarioHealth Corp. stock, with the latest data on short interest released on June 30, 2020, showing that short interest numbers in the DRIO shares have declined. Short interest in the stock represents just 0.24% of its float, but the volume has dropped by -12736. The volume of shorted shares dropped to 6415 from 19151 shares over the last two weeks. The average intraday trading volume has been 24164 shares, which means that days to cover moved to roughly 1.

In the last trading session, DarioHealth Corp. (NASDAQ:DRIO) raised by $0.73 over the week and gained $0.53 on its 20-day. The stock’s high in the recent session is lower when compared to its 52-week high of $13.13. The stock recorded its established 52-week high on 07/31/19.

Since 03/19/20, the stock has traded to a low of $3.02 at 130.13%, an encouraging piece of data likely to interest most investors out to exploit the stock’s recent surge. The stock has a beta allocation of 0.48. Being above 1 means that the stock’s volatility is higher than the market and traders are keenly watching it.

Looking at current readings, DarioHealth Corp.’s two-week RSI is 55.92. This suggests that the stock is neutral at the moment and that DRIO shares’ price movement remains stable. The stochastic readings are equally revealing at 74.18% meaning the DRIO share price is currently in oversold territory.

The technical chart shows that the DRIO stock will likely settle at between $6.98 and $7.13 per share. However, if the stock dips below $6.69, then its market would become much weaker. Any downside could see the stock price sliding to levels as low as $6.55.

Currently, the stock is trading in the green of MACD, with a reading of 0.29. Investors always pay attention to any move above or below the zero-line, mainly because the indicator points to the position of the stock’s short-term average relative to its long-term measure. A MACD -a reading above the zero line means that the short-term is above the long-term average. This scenario implies that there is an upward momentum. The opposite is true when the MACD falls below the zero-line.

Analysts at Maxim Group assigned DRIO a rating of Buy in their intiating review released on August 29. Rodman & Renshaw analysts see the stock as a Buy with a target price of $12 in a flash note released to investors on May 09 initiating covering the stock.

The average rating for the DRIO equity is 2 and is currently gathering a bullish momentum. Of 3 analysts tracking DarioHealth Corp. polled by Reuters, 0 rated DRIO as a hold. The remaining 3 analysts were split evenly. However, the split wasn’t equal as a majority (3) rated it as a buy or strong buy. 0 analyst advised investors against buying the stock or to sell if they own any of the stock.

Elsewhere, the DRIO stocks P/S ratio currently stands below the group’s average of 61.5. DarioHealth Corp. has its P/E ratio at 1.7, which means that the stock is currently trading at a discount relative to the 6 industry average.

Zacks Consensus Estimate forecasts that the current-quarter revenues for DarioHealth Corp. (NASDAQ:DRIO) will decrease by about -99.91%, which will see them reach $1.5 million. The company’s full-year revenues are, however, expected to diminish by about -6.48%, down from $7.56 million to $7.07 million. DRIO’s expected adjusted earnings should drop almost -48.08% to end up at -$1.35 per share, while for the fiscal year, analysts project the company’s earnings to drop by about -25.5% to record -$5.96/share.

LEAVE A REPLY

Please enter your comment!
Please enter your name here